Topical terbinafine (Lamisil®) for superficial mycoses:: High cure rates in short treatment times

被引:1
|
作者
Evans, EGV [1 ]
机构
[1] Univ Leeds, Dept Microbiol, PHLS Mycol Reference Lab, Leeds LS2 9JT, W Yorkshire, England
[2] Gen Infirm, Leeds LS2 9JT, W Yorkshire, England
关键词
terbinafine; tinea pedis/corporis/cruris; pityriasis versicolor;
D O I
10.3109/09546639809160711
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
This review article compares the use of fungicidal terbinafine 1% cream in superficial mycoses with other more established and largely fungistatic agents. Topical azoles need to be applied two or three times daily for 4-6 weeks, whereas terbinafine has achieved cure rates in tinea pedis of 80-90% after only 1 or 2 weeks' treatment. Terbinafine twice daily for 1 week compared with clotrimazole twice daily for 4 weeks has produced mycological cure rates of 97.2% and 83.7%, respectively: a statistically significant result in favour of terbinafine. Terbinafine for 2 weeks produced a mycological cure in 69% of patients with moccasin-type tinea pedis. Treatment for 1-2 weeks with topical terbinafine has produced cure rates of 80-90% in tinea corporis and tinea cruris. Results have been similar in cutaneous candidosis and pityriasis versicolor. Two new terbinafine formulations are discussed: the 1% solution and 1% emulsion gel. One week's treatment with both formulations produces mycological cure rates in tinea pedis of 86% and 88% and in tinea corporis/cruris of 85% and 83%, respectively. Cure rates of 70-76% have been achieved in pityriasis versicolor after 1 week's treatment with the new formulations. The cream, solution and emulsion gel are all well tolerated, Though such newer drugs are relatively expensive, the much reduced duration of treatment and higher cure rates make them more cost-effective.
引用
收藏
页码:S13 / S16
页数:4
相关论文
共 50 条
  • [31] HIGH CURE RATES OF THE SHORT-TERM GRUPPO ITALIANO TERAPIE INNOVATIVE NEI LINFOMI CHEMOTHERAPY PROGRAM FOR ADULT PATIENTS WITH BURKITT LYMPHOMA
    Mariotti, J.
    Guidetti, A.
    Cabras, A.
    Ponzoni, M.
    Dalto, S.
    De Renzo, A.
    Luzi, G.
    Patti, C.
    Corradini, P.
    Gianni, A. M.
    Ferreri, A. J.
    Di Nicola, M.
    HAEMATOLOGICA, 2015, 100 : 96 - 96
  • [32] High cure rates in Burkitt lymphoma and leukemia: a Northern Italy Leukemia Group study of the German short intensive rituximab-chemotherapy program
    Intermesoli, Tamara
    Rambaldi, Alessandro
    Rossi, Giuseppe
    Delaini, Federica
    Romani, Claudio
    Pogliani, Enrico Maria
    Pagani, Chiara
    Angelucci, Emanuele
    Terruzzi, Elisabetta
    Levis, Alessandro
    Cassibba, Vincenzo
    Mattei, Daniele
    Gianfaldoni, Giacomo
    Scattolin, Anna Maria
    Di Bona, Eros
    Oldani, Elena
    Parolini, Margherita
    Goekbuget, Nicola
    Bassan, Renato
    HAEMATOLOGICA, 2013, 98 (11) : 1718 - 1725
  • [33] High early death rates, treatment resistance, and short survival of Black adolescents and young adults with AML
    Larkin, Karilyn T.
    Nicolet, Deedra
    Kelly, Benjamin J.
    Mrozek, Krzysztof
    LaHaye, Stephanie
    Miller, Katherine E.
    Wijeratne, Saranga
    Wheeler, Gregory
    Kohlschmidt, Jessica
    Blachly, James S.
    Mims, Alice S.
    Walker, Christopher J.
    Oakes, Christopher C.
    Orwick, Shelley
    Boateng, Isaiah
    Buss, Jill
    Heyrosa, Adrienne
    Desai, Helee
    Carroll, Andrew J.
    Blum, William
    Powell, Bayard L.
    Kolitz, Jonathan E.
    Moore, Joseph O.
    Mayer, Robert J.
    Larson, Richard A.
    Stone, Richard M.
    Paskett, Electra D.
    Byrd, John C.
    Mardis, Elaine R.
    Eisfeld, Ann-Kathrin
    BLOOD ADVANCES, 2022, 6 (19) : 5570 - 5581
  • [34] 'Treatment options in early stages of Hodgkin's lymphoma, high cure rate with lower short and long-term toxicity
    Pavlovsky, S
    HEMATOLOGY, 2005, 10 : 3 - 5
  • [35] Nurse-Administered Propofol in a Small Community GI Lab Is Associated With Short Procedure Times, Safety and High Cecum Intubation RATES
    Ramirez, Francisco E.
    Olafsson, Snorri
    Lively, David
    Nedley, Neil
    GASTROINTESTINAL ENDOSCOPY, 2015, 81 (05) : AB221 - AB221
  • [36] High cure rates and tolerability of artesunate-amodiaquine and dihydroartemisinin-piperaquine for the treatment of uncomplicated falciparum malaria in Kibaha and Kigoma, Tanzania
    Mandara, Celine I.
    Francis, Filbert
    Chiduo, Mercy G.
    Ngasala, Billy
    Mandike, Renata
    Mkude, Sigsbert
    Chacky, Frank
    Molteni, Fabrizio
    Njau, Ritha
    Mohamed, Ally
    Warsame, Marian
    Ishengoma, Deus S.
    MALARIA JOURNAL, 2019, 18 (1)
  • [37] FRACTIONATED SHORT-TIME-AFTERLOADING WITH HIGH-DOSE RATES IN AMBULANT TREATMENT OF INOPERABLE ENDOMETRIAL CARCINOMA
    KUCERA, H
    UNEL, N
    WEGHAUPT, K
    GEBURTSHILFE UND FRAUENHEILKUNDE, 1983, 43 (07) : 456 - 460
  • [38] SEPARATION OF MAGNETIC AND QUADRUPOLAR RELAXATION RATES FROM SPIN-LATTICE RECOVERY LAWS AT SHORT TIMES WITH ILLUSTRATION IN A HIGH-TC SUPERCONDUCTOR
    REGA, T
    JOURNAL OF PHYSICS-CONDENSED MATTER, 1991, 3 (12) : 1871 - 1876
  • [39] Lowest acquisition drug cost directly acting antiviral (DAA) treatment for hepatitis C (HCV): high cure rates in a difficult to treat HIV/HCV population
    Agarwal, K.
    Childs, K.
    Sawieres, S.
    Taylor, C.
    Johansen, S.
    Kulasegaram, R.
    Paparello, J.
    HIV MEDICINE, 2017, 18 : 39 - 39
  • [40] A Prototype Continuous Nebulizer Offers Clinicians Short Treatment Times Combined with High Respirable Dose for Efficient Lung Delivery: A Comparative Laboratory Study
    Suggett, J.
    Nagel, M.
    Coppolo, D.
    Mitchell, J.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197